Orbivestus leopoldi
Orbivestus leopoldi · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Orbivestus leopoldi is a botanical species that has garnered significant scientific interest due to its potential therapeutic properties. Recent investigations have focused on its remarkable anticancer activities, particularly in targeting resilient cell populations. Research specifically examines the plant's ability to combat cancer stem cells, which are often responsible for tumor recurrence and resistance. These studies utilize various preparations, including crude extracts and the refined ethyl acetate fraction, to isolate bioactive compounds. Understanding these mechanisms offers promising insights into the development of novel oncological treatments.
- Synonyms
- Cyanopis Leopoldi · Vernonia Leopoldi · 1 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Synonyms
Orbivestus leopoldi is a botanical species that has been identified through various taxonomic classifications over time. Due to shifts in scientific nomenclature, this plant is recognized by several different formal names. It is officially documented under the synonym Cacalia leopoldi in certain historical records. Additionally, the species has been referred to as Cyanopis leopoldi and Vernonia leopoldi in previous studies. Understanding these multiple synonyms is essential for researchers tracking the plant's true identity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Orbivestus leopoldi is a remarkable specimen that belongs to the vast kingdom Plantae. Within this biological kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Asterales, showcasing its unique evolutionary lineage. As a member of the family Asteraceae, it shares characteristics with many well-known flowering species. Ultimately, this plant is identified by its distinct genus, Orbivestus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Orbivestus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Orbivestus leopoldi maintains a fascinating geographical range that spans across two major continents. In Africa, this species is primarily found throughout Northeast Tropical Africa, specifically within the territories of Djibouti and Ethiopia. Its presence extends further into the Asia-Temperate region, where it inhabits the unique landscapes of the Arabian Peninsula. Within this peninsula, the plant is documented to thrive in both Saudi Arabia and Yemen. This wide distribution highlights the remarkable adaptability of the species across diverse ecological zones.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Orbivestus leopoldi stands out as a significant botanical resource within the rich medicinal landscape of Ethiopia. According to recent literature reviews, this species has demonstrated powerful anticancer activity, particularly when evaluated through its crude extracts. It belongs to a diverse group of Ethiopian medicinal plants that are frequently utilized by local populations to manage various types of tumors and cancers. Scientific evidence suggests that such plants may possess high potency, with some achieving impressive IC50 values in laboratory settings. Continued research into these species is essential to potentially isolate safe and cost-effective therapeutic agents for modern oncology.
Compounds
Conditions
Vernonia leopoldi (noted as Orbivestus leopoldi in the prompt) serves as a powerful anticancer agent due to its potent cytotoxic effects. Research indicates that its crude extracts demonstrate significant anticancer activity with an IC50 value below 10 μg/mL. Furthermore, the plant possesses specific anti-cancer stem cell potential, particularly through its ethyl acetate fraction. This fraction has been shown to significantly inhibit tumor necrosis factor-α-induced nuclear factor-kappa B translocation in breast cancer cell lines. Such properties suggest that the plant plays a critical role in targeting both general cancer cells and the specific subpopulations responsible for tumor progression.
Preparations
Orbivestus leopoldi is prepared as crude extracts that have demonstrated powerful anticancer properties with an IC50 value below 10 μg/mL. In addition to these crude forms, the plant is prepared as an ethyl acetate fraction derived from methanolic extracts. This specific ethyl acetate fraction has shown the ability to significantly inhibit tumor necrosis factor-α-induced nuclear factor-kappa B translocation to the nucleus. These various preparations highlight the medicinal potential of the species in treating cancer cell lines. The study of these specific plant preparations underscores their efficacy in targeting breast cancer stem cell activities.